US Dollar vs Yen

登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

ホーム
投資
株式
アメリカ
NASDAQ
LENZ Therapeutics Inc (LENZ)
LENZ Therapeutics Inc (LENZ) ニュース

LENZ Therapeutics Inc (LENZ)

6.15

-0.19

(-3.00%)

終了 6月19日 5:00AM

6.05

-0.10

(-1.63%)

取引時間後: 8:09AM

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 8-K - Current report

LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China

SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”...

LENZ Therapeutics to Participate in Upcoming Investor Conferences

SAN DIEGO, May 26, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights

Q1 2026 total revenue of $1.9 million, including $1.7 million in VIZZ® product sales Approximately 46,000 paid...

LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the...

Form ARS - Annual Report to Security Holders

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

MHRA submission follows EMA validation of the VIZZ MAA in March 2026 Sixth ex-U.S. regulatory submission for...

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

joyceschoice

joyceschoice 3月前

Taking a starter position in this one @ 8.63. I'm often early but feel this one will be ready for a reversal soon.

Laster

Ok. Today is much better. Just don’t crash at EOD.
Hold $40 or $41. That would be really bullish.
I think this stock has a chance to recover back to $50 by EOY.
How are those drops selling????

Laster

Back in because I like to torture myself.
It was doing well today until Trump text about soybeans and China.
Don’t know how this relates to LENZ or biotechs but it dropped afterward.
Looking for any positive news on sales of their eye drops.

Laster

Company dilutes and stock drops 8%.
There is something really wrong here.
I’m out. Good luck.

Laster

Stock dumping because the company is diluting.
Absolutely horrible.

Laster

That’s more like it. $50 baby.
October they start selling their eye drops.
When they announce monthly results the stock will continue to move higher.
I think it is still very cheap. Likely buyout candidate within 6 months.
JMO.

Laster

This stock is bipolar.
Up 5% Friday and down 6% today.
No news. This market is strange.
I don’t get how it went under $40 today.

Laster

Amazing way to close out the week. $42!
I really think this can ru to $45 by end of the month.
$50 by end of the year if they have good news with their VIZZ eye drops.
Can’t wait to try them out.

Laster

52 week high today.
I am buying this product when it goes on sale.
This product is needed for most people over 40.
Looking for $45 by end of month going into October when VIZZ goes on market.

Laster

Looking for this stock to break $40 for good.
The next few months should be very Interesting.
I just don’t see how this doesn’t move to $50 or higher by EOY.
JMO.

Laster

Laster 10月前

I think it is ready for a move past $41 to $45.
PnF chart looks ready. MACD histo on 4-hr chart just turned positive.
Just hope the market doesn’t get affected by Powell or Trump today.
I think this company gets bought out at $75 or higher. JMO.
Here is pnf chart from stockcharts.com.

https://stockcharts.com/freecharts/pnf.php?c=lenz,P

Laster

Laster 10月前

Nice recovery today.
Hoping for $40 by EOW.
Fingers crossed.

Laster

Laster 10月前

Trying find support on awful stock market day.
Every stock I follow is in the red.
Curious what happened today.

Laster

Laster 10月前

PnF chart looks good if it can move back to $41 and get to $42.
Double top breakout on its way to $50.
Any news will get you there.
JMO.

Laster

Laster 10月前

Break $40 and I think it moves to $45 by EOM.
Chart looks good.
Great story. Short squeeze.

Laster

Laster 10月前

Break $39 with volume and run.
Huge relative short interest.
Could it squeeze?

Laster

Laster 10月前

Nice pre-market activity only to fall at 9:30 AM open.
I was hoping for buyout ;))) But oh well.
Huge resistance at $39 (prior high). It will need lots of volume to pass $39.
If it moves past $40 then I think it has a shot at $45 this week.
But maybe I am just a little too optimistic.
Good trading.

Laster

Laster 10月前

Someone on twitter with over 2 million followers just talked about LENZ. Closed AH near $37. I really see someone buying them out for $75 or more. I will seriously start using these drops when they become available.
JMO.

Laster

Laster 10月前

They must be a buyout candidate. Just got FDA approval.
I actually need their eye drops.
This is a no brainer IMO.

Monksdream

Monksdream 2年前

Monksdream

Monksdream 2年前

LENZ volatile stock

LENZ Therapeutics

United Internet (PK)

Intesa Sanpaolo

Amundi Bberg Equal weigh...

Cleveland Cliffs

Wessex Water Services Fi...

Leverage Shares 2x Advan...

Vontobel Financial Produ...

Bayer Aktiengesellschaft (QX)

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。